The role of antimicrobial agents in the aetiology of Clostridium difficile-associated disease

Journal of Antimicrobial Chemotherapy

Volumn 41, Issue SUPPL. C, 1998, Pages 21-27

  Spencer, Robert C ^a  

^a BRISTOL ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CEPHALOSPORIN; CIPROFLOXACIN; CLINDAMYCIN; GENTAMICIN; PENICILLIN G; TRIMETHOPRIM; UREIDOPENICILLIN;

BACTERIAL INFECTION; CLOSTRIDIUM DIFFICILE; DRUG USE; EDUCATION; GERIATRIC CARE; HUMAN; REVIEW;

ANTI-BACTERIAL AGENTS; CEPHALOSPORINS; CLOSTRIDIUM DIFFICILE; ENTEROCOLITIS, PSEUDOMEMBRANOUS; HUMANS;

EID: 0031972134     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/41.suppl_3.21     Document Type: Review

References (74)

1. Cartmill, T. D. I., Panigrahi, H., Worsley, M. A., McCann, D. C., Nice, C. N. & Keith, E. (1994). Management and control of a large outbreak of diarrhoea due to Clostridium difficile. Journal of Hospital Infection 27, 1-15.
2. Brown, E., Talbot, G. H., Axelrod, P., Provencher, M. & Hoegg, C. (1990). Risk factors for Clostridium difficile toxin-associated diarrhea. Infection Control and Hospital Epidemiology 11, 283-90.
3. Kelly, C. P., Polhoulakis, C. & LaMont, J. T. (1994). Clostridium difficile colitis. New England Journal of Medicine 330, 257-62.
4. Borriello, S. P. (1990). The influence of the normal flora on Clostridium difficile colonisation of the gut. Annals of Medicine 22, 61-7.
5. Fekety, R. (1995). Antibiotic associated colitis. In Mandell, Douglas and Bennett's Principles and Practice of Infectious Diseases, 4th edn (Mandell, G. L., Bennett, J. E. & Dolin, R., Eds), pp. 978-87. Churchill Livingstone, New York.
6. Nelson, D. E., Auerbach, S. B., Baltch, A. L., Desjardin, E., Beck-Sague, C., Rheal, C. et al. (1994). Epidemic Clostridium difficile-associated diarrhoea: role of second- and third-generation cephalosporins. Infection Control and Hospital Epidemiology 15, 88-94.
7. Aronsson, B., Mollby, R. & Nord, C. E. (1985). Antimicrobial agents and Clostridium difficile in acute enteric disease: epidemiological data from Sweden, 1980-1982. Journal of Infectious Diseases 151, 476-81.
8. Groschell, D. H. (1996). Clostridium difficile infection. Critical Reviews in Clinical and Laboratory Sciences 33, 203-45.
9. Bartlett, J. G. (1981). Antimicrobial agents implicated in Clostridium difficile toxin-associated diarrhea or colitis. Johns Hopkins Medical Journal 149, 6-9.
10. Aronsson, B., Mollby, R. & Nord, C. E. (1984). Diagnosis and epidemiology of Clostridium difficile enterocolitis in Sweden. Journal of Antimicrobial Chemotherapy 14, Suppl. D, 85-95.
11. Bartlett, J. G., Taylor, N. S., Chang, T. & Dzink, J. (1980). Clinical and laboratory observations in Clostridium difficile colitis. American Journal of Clinical Nutrition 33, Suppl., 2521-6.
12. Church, J. M. & Fazio, V. M. (1986). A role for colonic stasis in the pathogenesis of disease related to Clostridium difficile. Diseases of the Colon and Rectum 29, 804-9.
13. Bartlett, J. G. (1992). Antibiotic-associated diarrhea. Clinical Infectious Diseases 15, 573-81.
14. de Lalla, F., Privitera, G., Ortisi, G., Rizzardini, G., Santoro, D., Pagano, A. et al. (1989). Third generation cephalosporins as a risk factor for Clostridium difficile-associated disease: a four-year survey in a general hospital. Journal of Antimicrobial Chemotherapy 23, 623-31.
15. Finegold, S. M. (1986). Clinical considerations in the diagnosis of antimicrobial agent-associated gastroenteritis. Diagnostic Microbiology and Infectious Diseases 4, Suppl. 3, S87-91.
16. George, W. L., Rolfe, R. D. & Finegold, S. M. (1982). Clostridium difficile and its cytotoxin in feces of patients with antimicrobial agent-associated diarrhea and miscellaneous conditions. Journal of Clinical Microbiology 15, 1049-53.
17. Talbot, R. W., Walker, R. C. & Beart, R. W. (1986). Changing epidemiology, diagnosis, and treatment of Clostridium difficile toxin-associated colitis. British Journal of Surgery 73, 457-60.
18. George, W. L. (1988). Antimicrobial agent-associated diarrhoea in adult humans. In Clostridium difficile - its Role in Intestinal Disease (Rolfe, R. D. & Finegold, S. M., Eds), pp. 31-44. Academic Press, London.
19. Bartlett, J. G. (1990). Clostridium difficile: clinical considerations. Reviews of Infectious Diseases 12, Suppl. 2, S243-51.
20. De Courcy, J. & Mackinnon, J. (1985). Pseudomembranous colitis and trimethoprim. British Medical Journal 290, 1112.
21. Golledge, C. L., Carson, C. F., O'Neill, G. L., Bowman, R. A. & Riley, T. V. (1992). Ciprofloxacin and Clostridium difficile-associated diarrhoea. Journal of Antimicrobial Chemotherapy 30, 141-7.
22. Anand, A., Bashey, B., Mir, T. & Glatt, A. E. (1994). Epidemiology, clinical manifestations and outcome of Clostridium difficile-associated diarrhea. American Journal of Gastroenterology 89, 519-23.
23. Gerding, D. N., Olson, M. M., Peterson, L. R., Teasley, D. G., Gebhard, R. L., Schwartz, M. L. et al. (1986). Clostridium difficile-associated diarrhea and colitis in adults. A prospective case-controlled epidemiologic study. Archives of Internal Medicine 146, 95-100.
24. George, W. L. (1980). Antimicrobial agent-associated colitis and diarrhea. Western Journal of Medicine 133, 115-23.
25. George, W. L., Rolfe, R. D. & Finegold, S. M. (1982). Clostridium difficile and its cytotoxin in feces of patients with antimicrobial agent-associated diarrhea and miscellaneous conditions. Journal of Clinical Microbiology 15, 1049-53.
26. Silva, J., Fekety, R., Werk, C., Ebright, J., Cudmore, M., Batts, D. et al. (1984). Inciting and etiologic agents of colitis. Reviews of Infectious Diseases 6, Suppl. 1, 214-21.
27. Starr, J. M. & Impallomeni, M. (1997). Risk of diarrhoea, Clostridium difficile and cefotaxime in the elderly. Biomedicine and Pharmacotherapy 51, 63-7.
28. Barc, M. C., Depitre, C., Cortimer, G., Collignon, A., Su, W. J. & Bourlioux, P. (1992). Effects of antibiotics and other drugs on toxin production in Clostridium difficile in vitro and in vivo. Antimicrobial Agents and Chemotherapy 36, 1332-5.
29. Tedesco, F. J., Barton, R. W. & Alpers, D. H. (1974). Clindamycin-associated colitis. A prospective study. Annals of Internal Medicine 81, 429-33.
30. Kabins, S. A. & Spira, T. J. (1975). Outbreak of clindamycin-associated colitis. Annals of Internal Medicine 83, 830-1.
31. Larson, H. E., Parry, J. V., Price, A. B., Davies, D. R., Dolby, J. & Tyrrell, D. A. J. (1977). Undescribed toxin in pseudomembranous colitis. British Medical Journal i, 1246-8.
32. Bartlett, J. G., Onderdonk, A. B., Cisneros, R. L. & Kasper, D. L. (1977). Clindamycin-associated colitis due to toxin-producing species of Clostridium in hamsters. Journal of Infectious Diseases 136, 701-5.
33. Golledge, C. L., McKenzie, T. & Riley, T. V. (1989). Extended spectrum cephalosporins and Clostridium difficile. Journal of Antimicrobial Chemotherapy 23, 929-31.
34. Ho, M., Young, D., Wyle, F. A. & Mulligan, M. E. (1996). Increased incidence of Clostridium difficile-associated diarrhea following decreased restriction of antibiotic use. Clinical Infectious Diseases 23, Suppl. 1, S102-6.
35. Impallomeni, M., Galletly, N. P., Wort, S. J., Starr, J. M. & Rogers, T. R. (1995). Increased risk of diarrhoea caused by Clostridium difficile in elderly patients receiving cefotaxime. British Medical Journal 311, 1345-6.
36. Green, S. T., Mackie, R., McMillan, H. & Davie, J. W. (1985). Clostridium difficile-induced colitis occuring during cefotaxime therapy. Ulster Medical Journal 54, 80-2.
37. Eley, A. & Greenwood D. (1981). In-vitro activity of ceftizoxime against Bacteroides fragilis: comparison with benzyl penicillin, cephalothin and cefoxitin. Antimicrobial Agents and Chemotherapy 20, 332-5.
38. Canawati, H. N. (1992). A reassessment of the activity of the third-generation cephalosporins against anaerobes and Staphylococcus aureus. American Journal of Surgery 164, Suppl. 4A, S24-7.
39. Bates, C. J., Wilcox, M. H., Spencer, R. C. & Harris, D. M. (1990). Ciprofloxacin and Clostridium difficile infection. Lancet 336, 1193.
40. Cain, D. B. & O'Connor, M. E. (1990). Pseudomembranous colitis associated with ciprofloxacin. Lancet 336, 946.
41. Hillman, R. J., Gopal Rao, G., Harris, J. R. W. & Taylor-Robinson, D. (1990). Ciprofloxacin as a cause of Clostridium difficile-associated diarrhoea in an HIV antibody positive patient. Journal of Infection 21, 205-7.
42. Low, N. & Harries, A. (1990). Ciprofloxacin and pseudomembranous colitis. Lancet 336, 1510.
43. McFarland, L. V., Bauvens, J. E., Melcher, S. H., Surawicz, C. M., Greenberg, R. N. & Elmer, G. W. (1995). Ciprofloxacin associated Clostridium difficile disease. Lancet 346, 977-8.
44. Falsen, E. B., Nehls, L., Nygren, B. & Svedhem, A. (1980). Clostridium difficile in relation to enteric bacterial pathogens. Journal of Clinical Microbiology 12, 297-300.
45. Riley, T. V., Bowman, R. A. & Carroll, S. M. (1983). Diarrhoea associated with Clostridium difficile in a hospital population. Medical Journal of Australia i, 166-9.
46. Braegger, C. P. & Nadal, D. (1995). Clarithromycin and pseudomembranous enterocolitis. Lancet 343, 241-2.
47. Teare, J. P., Booth, J. C., Brown, J. L., Martin, J. & Thomas, H. C. (1995). Pseudomembranous colitis following clarithromycin therapy. European Journal of Gastroenterology and Hepatology 7, 275-7.
48. Gineston, J. L., Watine, J., Bruna, T., Lamblin, G. & Dubourdieu, B. (1993). Colite aigue hemorragique a la pristinamycine: 2 cas avec association de Klebsiella oxytoca et de Clostridium difficile. Gastroenterologie Clinique et Biologique 17, 773-5.
49. Gordin, F., Gibert, C. & Schmidt, M. E. (1994). Clostridium difficile colitis associated with trimethoprim-sulfamethoxazole given as prophylaxis for Pneumocystis carinii pneumonia. American Journal of Medicine 96, 94-5.
50. Golledge, C. L. & Riley T. V. (1995). Clostridium difficile-associated diarrhoea after doxycycline malaria prophylaxis. Lancet 345, 1377-8.
51. Riley, T. V., Wetherall, F., Bowman, J., Mogyorosy, J. & Golledge, C. L. (1991). Diarrheal disease due to Clostridium difficile in general practice. Pathology 23, 346-9.
52. Jobe, B. A., Grasley, A., Deveney, K. E., Deveney, C. W. & Sheppard, B. C. (1995). Clostridium difficile colitis: an increasing hospital-acquired illness. American Journal of Surgery 169, 480-3.
53. Yee, J., Dixon, C. M., McLean, A. P. & Meakins, J. L. (1991). Clostridium difficile disease in a department of surgery. The significance of prophylactic antibiotics. Archives of Surgery 126, 241-6.
54. Privitera, G., Scarpellini, P., Ortisi, G., Nicastro, G., Nicolin, R. & de Latta, F. (1991). Prospective study of Clostridium difficile intestinal colonization and disease following single dose antibiotic prophylaxis in surgery. Antimicrobial Agents and Chemotherapy 35, 208-10.
55. Arsura, E. L., Fazio, R. A. & Wickremesinghe, P. C. (1985). Pseudomembranous colitis following prophylactic antibiotic use in primary cesarian section. American Journal of Obstetrics and Gynecology 151, 87-9.
56. Block, B. S., Mercer, L. J., Ismail, M. A. & Moawad, A. H. (1985). Clostridium difficile-associated diarrhea follows peri-operative prophylaxis with cefoxitin. American Journal of Obstetrics and Gynecology 153, 835-8.
57. Roberts, A. P. & Hughes, A. W. (1985). Complications with antibiotics used prophylactically in joint replacement surgery: a case report of cephradine-induced pseudomembranous colitis. International Orthopaedics 8, 299-302.
58. Tan, J., Bayne, L. H. & McLeod, P. J. (1979). Pseudomembranous colitis. A fatal case following prophylactic cephaloridine therapy. Journal of the American Medical Association 242, 749-50.
59. Bodey, G. P., Fainstein, V., Garcia, I., Rosenbaum, B. & Wong, Y. (1983). Effect of broad-spectrum cephalosporins on the microbial flora of recipients. Journal of Infectious Diseases 148, 892-7.
60. Ambrose, N. S., Johnson, M., Burdon, D. W. & Keighley, M. R. B. (1985). The influence of single dose intravenous antibiotics on faecal flora and emergence of Clostridium difficile. Journal of Antimicrobial Chemotherapy 15, 319-26.
61. Kreisel, D., Savel, T. C., Silver, A. L. & Cunningham, J. D. (1995). Surgical antibiotic prophylaxis and Clostridium difficile toxin positivity. Archives of Surgery 130, 989-93.
62. Department of Health and Public Health Laboratory Service Joint Working Group. (1994). Clostridium difficile Infection. Prevention and Management. BAPS Health Publication Unit, Heywood, Lancs.
63. Swindell, P. J., Reeves, D. S., Bullock, D. W., Davies, A. J. & Spence, C. E. (1983). Audits of antibiotic prescribing in a Bristol Hospital. British Medical Journal 286, 118-22.
64. Kunin, C. M. (1977). Guidelines and audits for use of antimicrobial agents in hospitals. Journal of Infectious Diseases 135, 335-6.
65. Cooke, D., Salter, A. J. & Phillips, I. (1980). Antimicrobial misuse, antibiotic policies and information resources. Journal of Antimicrobial Chemotherapy 6, 435-43.
66. Marr, J. J., Moffet, H. L & Kunin, C. M. (1988). Guidelines for improving the use of antimicrobial agents in hospitals: a statement by the Infectious Diseases Society of America. Journal of Infectious Diseases 157, 869-76.
67. Avorn, J. & Soumerai, S. B. (1983). Improving drug therapy decisions through educational outreach. A randomized controlled trial of academically based 'detailing'. New England Journal of Medicine 308, 1457-63.
68. Avorn, J., Soumerai, S. B., Taylor, W., Wessels, M. R., Janousek, J. & Weiner, M. (1988). Reduction of incorrect antibiotic dosing through a structured educational order form. Archives of Internal Medicine 148, 1720-4.
69. Collier, J. & Foster, J. (1985). Management of a restricted drugs policy in hospital: the first five years' experience. Lancet i, 331-3.
70. Feely, J., Chan, R., Cocoman, L., Mulpeter, K. & O'Connor, P. (1990). Hospital formularies: need for continous intervention. British Medical Journal 300, 28-30.
71. British Thoracic Society. (1993). Guidelines for the management of community-acquired pneumonia in adults admitted to hospital. British Journal of Hospital Medicine 49, 346-50.
72. MacGowan, A., Feeney, R., Brown, I., McCulloch, S. Y., Reeves, D. S. & Lovering, A. M. (1997). Health care resource utilization and antimicrobial use in elderly patients with community-acquired lower respiratory tract infection who develop Clostridium difficile-associated diarrhoea. Journal of Antimicrobial Chemotherapy 39, 537-41.
73. Jones, E. M., Kirkpatrick, B. L., Feeney, R., Reeves, D. S. & MacGowan, A. P. (1997). Hospital-acquired Clostridium difficile diarrhoea. Lancer 349, 1176-7.
74. McNulty, C., Logan, M., Donald, I. P., Ennis, D., Taylor, D., Baldwin, R. N. et al. (1997). Successful control of Clostridium difficile infection in an elderly care unit through use of a restrictive antibiotic policy. Journal of Antimicrobial Chemotherapy 40, 707-11.